8-K1.018.019.01
SECURITIES AND EXCHANGE COMMISSION
SPRO: SECURITIES AND EXCHANGE COMMISSION
EDGARSPRO: SECURITIES AND EXCHANGE COMMISSION
Spero Therapeutics Inc (SPRO) just filed. SPRO: SECURITIES AND EXCHANGE COMMISSION (8-K 2026-08-28).
Those exhibit numbers sit next to the income-statement cache: Latest reported SPRO revenue for 2025-09-30 was $5.4M. Net income was -$7.4M. Revenue was down 61.6% from 2025-06-30 to 2025-09-30. SPRO currently screens at market cap $149.5M and trailing P/E 9.6. The SPRO filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Spero Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
8-KEX-99.11.018.019.01
SECURITIES AND EXCHANGE COMMISSION
SPRO: SECURITIES AND EXCHANGE COMMISSION
Source on EDGAR0
10-K
0
10-Q
3
8-K
0
Form 4
Recent filings
EDGAR is the official archive. Browse all SPRO filings.
Frequently asked questions
What did SPRO just say?
SPRO: SECURITIES AND EXCHANGE COMMISSION
Where are SPRO SEC filings?
3 cached filings are on this page. EDGAR remains the official archive (CIK 0001701108).
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.